More SEC Filings
View Older Stories View Newer Stories-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Olson Jeffrey S
-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Mooallem Jeffrey
-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Ohlberg Heather
-
Form 4 Urban Edge Properties For: Jan 27 Filed by: Langer Mark
-
Form S-1MEF M Evo Global Acquisition
-
Form 4 Sarepta Therapeutics, For: Jan 29 Filed by: Nicaise Claude
-
Form 4 Sarepta Therapeutics, For: Jan 27 Filed by: BEHRENS M KATHLEEN
-
Form 4 TKO Group Holdings, Inc. For: Jan 27 Filed by: KRAUSS SETH D
-
Form 4 TKO Group Holdings, Inc. For: Jan 27 Filed by: Kapral Shane
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Cohen Douglas Jay
-
Form SCHEDULE 13G/A Ventyx Biosciences, Inc. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A Verrica Pharmaceuticals Filed by: Affinity Asset Advisors, LLC
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Murphy Keith
-
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Affinity Asset Advisors, LLC
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Affinity Asset Advisors, LLC
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Milhous Alison Tjosvold
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Gobel David
-
Form 4 USA Rare Earth, Inc. For: Jan 29 Filed by: Trabuco Carolyn
-
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: STERN ADAM K
-
Form SCHEDULE 13D/A NovaBay Pharmaceuticals, Filed by: Lazar David E.
-
Form 4 Ainos, Inc. For: Jan 28 Filed by: Taiwan Carbon Nano Technology Corp
-
Form 4 NovaBay Pharmaceuticals, For: Oct 21 Filed by: Lazar David E.
-
Form 144 GeneDx Holdings Corp. Filed by: Feeley Kevin
-
Form 144 GeneDx Holdings Corp. Filed by: Stueland Katherine
-
Form 4 System1, Inc. For: Jan 28 Filed by: Kidambi Tridivesh
-
Form 4 System1, Inc. For: Jan 28 Filed by: Sestanovich Elizabeth
-
Form 4 System1, Inc. For: Jan 28 Filed by: Coppola Brian
-
Form 4 System1, Inc. For: Jan 28 Filed by: Weinrot Daniel J
-
Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu
-
Form 4 MICRON TECHNOLOGY INC For: Jan 27 Filed by: RAY MICHAEL CHARLES
-
Form SCHEDULE 13D/A LanzaTech Global, Inc. Filed by: Khosla Ventures III, L.P.
-
Form 4 LanzaTech Global, Inc. For: Jan 21 Filed by: KHOSLA VINOD
-
Form SCHEDULE 13G/A Lincoln Bain Capital Filed by: Lincoln Financial Investments Corp
-
Form 3 Skillsoft Corp. For: Dec 08 Filed by: Barbour Bernard
-
Form 4 TRUPANION, INC. For: Jan 28 Filed by: GALLAGHER JOHN R
-
Form SCHEDULE 13G Integra Resources Corp. Filed by: Hillsdale Investment Management Inc.
-
Form 4 AMERIPRISE FINANCIAL For: Jan 27 Filed by: Smyth Gerard P.
-
Form 4 AMERIPRISE FINANCIAL For: Jan 27 Filed by: CRACCHIOLO JAMES M
-
Form 4 AMERIPRISE FINANCIAL For: Jan 27 Filed by: Alvero Gumer
-
Form 4 AMERIPRISE FINANCIAL For: Jan 27 Filed by: Sweeney Joseph Edward
-
Form 4 AMERIPRISE FINANCIAL For: Jan 27 Filed by: Berman Walter Stanley
-
Form 4 AMERIPRISE FINANCIAL For: Jan 27 Filed by: TRUSCOTT WILLIAM F
-
Form 4 KINGSWAY FINANCIAL SERVI For: Jan 15 Filed by: Fitzgerald John Taylor Maloney
-
Form 4 AMERIPRISE FINANCIAL For: Jan 27 Filed by: Davies William
-
Form 144 Seagate Technology Holdi Filed by: Teh Ban Seng
-
Form 4 KINGSWAY FINANCIAL SERVI For: Jan 15 Filed by: Hansen Kent A
-
Form 3 M Evo Global Acquisition For: Jan 29 Filed by: Evolution Sponsor Holdings LLC II
